The therapy of the electric field improves survival with locally advanced pancreatic carcinoma
Add the electric field therapy Improve survival and pain control in patients with pancreas tumor Locally advanced, according to an international study, he brought Teresa Macarulla, a medical oncologist to the Vall d’Ebron Hospital and head of the group of superior gastrointestinal tumors and endocrine of Vhio.
The phase 3 clinical test It is presented This Sunday at the Congress of the American Society of Medical Oncology (Disgust) in Chicago and is published at the same time Journal of Clinical OncologyVhio reports in a declaration.
It shows that the addition of electric therapy on the field (TTFHIELDS) to the current treatment of gecitabine and nab-Paclitaxel improves Global survivalSurvival without pain and progression, free survival in patients with locally pancreatic adenocarcinoma advanced and inoperable.
Macarulla stressed that “so far No study Phase 3 “had shown an advantage in the survival of patients with locally advanced pancreatic adenocarcinoma, that is, that is, that is No operation.
Most patients with pancreatic adenocarcinoma have an advanced disease at the time of diagnosis, so it is difficult to treat: the prognosis It is unfavorablewith 5-year survival rates of 5-13%.
This therapy is administered with skin electrodes near the tumor that connects to a portable device that adapts to a backpack or a bandit: the device sends soft electric currents that act on cancer cells “Without influencing To close multiple healthy cells. “
The tumor treatment fields (TTFIELDS) are a Non -invasive therapy which uses low intensity electric fields that interrupt critical cell processes for the vitality of cancer cells e Tumor progression.
